Showing 2121-2130 of 23138 results for "".
Modern MS Management: Leveraging Technology to Support Brain Health
https://reachmd.com/programs/frontlines-multiple-sclerosis/modern-ms-management-leveraging-technology-to-support-brain-health/36388/New and evolving digital tools are opening opportunities to better detect, monitor, and personalize care for patients with multiple sclerosis. Dr. Gates Colbert sits down with Dr. Victoria Leavitt to learn about advances in digital assessments, imaging, and speech analysis that are reshaping how cliEvolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
https://reachmd.com/programs/deep-breaths-updates-chest/evolving-strategies-in-resectable-nsclc-insights-from-asco-and-astro-2025/35982/Recent data from ASCO and ASTRO 2025 are redefining standards of care for resectable non-small cell lung cancer (NSCLC). Drs. Gerard Silvestri, Mariam Alexander, Anurag Singh, and Jessica Donington review these updates on the importance of molecular testing, careful surgical selection, and multidiscImproving Colorectal Cancer Screening Adherence: Advantages of FIT
https://reachmd.com/programs/clinicians-roundtable/improving-colorectal-cancer-screening-adherence-advantages-of-fit/36703/For younger adults needing to get screened for colorectal cancer, fecal immunochemical testing (FIT) may help with initiation and adherence because of its speed, ease, and noninvasiveness. Hear Dr. Theodore Levin discuss FIT and its potential benefits, particularly in younger adults. Dr. Levin is aUsing FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
https://reachmd.com/programs/clinicians-roundtable/using-ftir-to-support-accurate-tissue-assessment-in-colorectal-surgery/36482/Fourier Transform Infrared (FTIR) spectroscopy is emerging as a powerful tool for distinguishing cancerous from noncancerous tissue during colorectal cancer surgery. In a recent study, Drs. Heather Allen and Ran Li leveraged a broad dataset from multiple sources to identify and validate biomarkers—mCADASIL Misdiagnosed as Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/cadasil-misdiagnosed-as-multiple-sclerosis/36652/The authors present a case of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy misdiagnosed as multiple sclerosis.Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
https://reachmd.com/programs/project-oncology/stratifying-ici-p-risk-in-non-small-cell-lung-cancer-with-genetic-and-radiographic-markers/35659/New data from MD Anderson highlights a promising approach to predicting ICI-associated pneumonitis (ICI-P) in patients with NSCLC. Learn about how the findings could help personalize ICI therapy, reduce adverse outcomes, and improve clinical decision-making for at-risk patients. This research was prThe Subtle Threats of Benzene on Airway Health: Insights from an In Vitro ALI Model
https://reachmd.com/programs/clinicians-roundtable/the-subtle-threats-of-benzene-on-airway-health-insights-from-an-in-vitro-ali-model/35658/A recent study published in the American Journal of Respiratory and Critical Care Medicine found that sub-cytotoxic benzene exposure can disrupt oxidative stress signaling and immune cell chemotaxis in airway epithelial cells without activating typical inflammatory of metabolic pathways. Read aboutLeading Dermatologists Summarize Maui Derm Presentations
https://reachmd.com/series/dermwire-tv/leading-dermatologists-summarize-maui-derm-presentations/32839/In this week's DermwireTV, top thought leaders provide a summary of their presentations at Maui Derm; a new analysis examines a link between hidradenitis suppurativa genetics and coronary artery disease risk; and the president of Castle Biosciences joins us for this week's C-Suite Chats fBreast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
https://reachmd.com/programs/project-oncology/breast-cancer-care-advancements-using-ai-to-detect-lymph-node-metastasis/26820/Tune in to learn how noninvasive AI techniques can be used to detect lymph node metastasis.Embracing the Diversifying Aesthetics Market
https://reachmd.com/ma-issues-index/2022-nov-dec/embracing-the-diversifying-aesthetics-market/35225/The aesthetics market is diversifying in terms of age, gender identity, and race and ethnicity.